Thanks you! It will be interesting to see if other studies confirm the findings. Long-term ADT comes with increased risk of heart disease, bone decay, type 2 diabetes, etc, so if our doctors can narrow down the situations where it's helpful, that will be a good thing. A single study doesn't get us there, but it's a start.

(Those of us with metastatic, castrate-sensitive prostate cancer *have* to take ADT to keep it under control, so the findings wouldn't affect me, but they could help when it's just a precautionary measure after treating early-stage PC).